Julien Haroche

High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses

Julien Haroche, Frédéric Charlotte, Laurent Arnaud et al. · Blood · 2012 · 693 citations

Medicine, Genetics, Molecular Genetics +10

Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease

Eli L. Diamond, Lorenzo Dagna, David M. Hyman et al. · Blood · 2014 · 586 citations · Full text

Medicine, Pathology, Pulmonology +3

Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort

Marie Pouletty, Charlotte Borocco, Naïm Ouldali et al. · Annals of the Rheumatic Diseases · 2020 · 551 citations · Full text

Medicine, Infectious Diseases, Pediatrics +16

Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms

Eli L. Diamond, Benjamin H. Durham, Julien Haroche et al. · Cancer Discovery · 2015 · 533 citations · Full text

Life Sciences, Molecular Biology, Molecular Genetics +10

Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation

Julien Haroche, Fleur Cohen‐Aubart, Jean‐François Emile et al. · Blood · 2012 · 530 citations

Medicine, Molecular Biology, Molecular Genetics +10